AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger

7 hours ago

Tie-up would be one of the biggest pharmaceutical deals ever and create the world’s fourth-largest drugmaker

Britain’s biggest drugmaker AstraZeneca is in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group.

AstraZeneca, run by longtime chief executive Pascal Soriot, is the second-biggest listed company in the UK, with a market value of nearly £196bn. BMS, headquartered in Princeton and known for its cancer treatments, is worth $133bn.

Continue reading...
Click here to Read More
Previous Article
Labour overtakes Reform in polls for first time in over a year
Next Article
Too hot to study: Will heatwaves impact school summer holidays in Europe?

Related World Updates:

Are you sure? You want to delete this comment..! Remove Cancel

Comments (0)

    Leave a comment